Targeting IL22: a potential therapeutic approach for Kras mutant lung cancer?
Transl Lung Cancer Res
.
2018 Sep;7(Suppl 3):S243-S247.
doi: 10.21037/tlcr.2018.09.04.
Authors
Frank D Weinberg
1
,
Nithya Ramnath
1
Affiliation
1
Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Rogel Cancer Center, Ann Arbor, MI 48109, USA.
PMID:
30393613
PMCID:
PMC6193907
DOI:
10.21037/tlcr.2018.09.04
No abstract available
Publication types
Editorial
Comment
Grants and funding
T32 CA009357/CA/NCI NIH HHS/United States